|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.100 EUR | 0.00% |
|
-1.39% | -7.79% |
| 02-26 | EARNINGS AND TRADING: Connecting Excellence hails record January fees | AN |
| 02-26 | Malin Corporation says CEO Fiona Dunlevy will leave Malin end of May | RE |
| Market Cap | 30.78M 34.98M 28.61M 26.26M 49.3M 3.38B 50.1M 340M 133M 1.66B 131M 128M 5.73B | P/E 2024 * |
-
| P/E 2025 | -8.37x |
|---|---|---|---|---|---|
| Enterprise Value | 17.88M 20.32M 16.62M 15.25M 28.64M 1.96B 29.1M 198M 77.07M 962M 76.28M 74.64M 3.33B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
63.83% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | -1.39% | ||
| Current month | -4.70% | ||
| 1 month | -4.70% | ||
| 3 months | -10.69% | ||
| 6 months | -10.13% | ||
| Current year | -7.79% |
| 1 week | 7.1 |  | 7.2 |
| 1 month | 7.1 | | 7.45 |
| Current year | 7 | | 8.45 |
| 1 year | 7 | | 9.3 |
| 3 years | 3.84 | | 10.4 |
| 5 years | 3.59 | | 10.4 |
| 10 years | 1.4 | | 14.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrea Stafford
DFI | Director of Finance/CFO | 56 | 30/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
William Daniel
CHM | Chairman | 73 | 01/08/2019 |
| Director/Board Member | 67 | 15/07/2018 | |
Rudy Mareel
BRD | Director/Board Member | 63 | 15/07/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02/06/26 | Fiscal year | 10,307 | 0.2382% | |||
| 28/05/25 | Fiscal year | Chief Executive Officer | 5,746 | 0.1328% | ||
| 07/04/25 | Sell | Director | 11,075 | 0.2560% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -1.39% | -13.41% | +57.08% | 35.04M | |
| +0.86% | +1.43% | +48.50% | +160.39% | 1,067B | |
| +1.59% | +4.09% | +55.34% | +53.96% | 635B | |
| +0.95% | +1.91% | +35.91% | +81.14% | 458B | |
| +1.60% | +6.25% | +33.95% | +29.84% | 347B | |
| -0.60% | +1.52% | +35.68% | +39.76% | 295B | |
| -0.14% | +0.60% | +16.17% | +17.53% | 262B | |
| +0.09% | -2.82% | -28.29% | -41.71% | 216B | |
| +1.22% | +2.66% | +21.87% | +59.73% | 203B | |
| -1.18% | -3.70% | +14.23% | +66.51% | 161B | |
| Average | +0.44% | +1.05% | +22.00% | +52.42% | 364.3B | |
| Weighted average by Cap. | +0.76% | +1.95% | +35.81% | +77.68% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | - | -6.9M -7.84M -6.41M -5.89M -11.05M -757M -11.23M -76.22M -29.74M -371M -29.44M -28.8M -1.29B |
| Net Debt | -62.1M -70.58M -57.73M -52.98M -99.47M -6.81B -101M -686M -268M -3.34B -265M -259M -11.57B | -12.9M -14.66M -11.99M -11.01M -20.66M -1.42B -21M -142M -55.61M -694M -55.04M -53.85M -2.4B |
Employees
2
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/07/26 | €7.100 | 0.00% | 1 |
| 23/07/26 | €7.100 | 0.00% | 2,490 |
| 22/07/26 | €7.100 | 0.00% | 1 |
| 21/07/26 | €7.100 | 0.00% | 0 |
| 20/07/26 | €7.100 | -1.39% | 81 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7.100EUR
Average target price
15.50EUR
Spread / Average Target
+118.31%
- Stock Market
- Stocks
- MLC Stock
Select your edition
All financial news and data tailored to specific country editions
